195 related articles for article (PubMed ID: 19407854)
1. Presence of cancer-associated fibroblasts inversely correlates with Schwannian stroma in neuroblastoma tumors.
Zeine R; Salwen HR; Peddinti R; Tian Y; Guerrero L; Yang Q; Chlenski A; Cohn SL
Mod Pathol; 2009 Jul; 22(7):950-8. PubMed ID: 19407854
[TBL] [Abstract][Full Text] [Related]
2. 'Cross-talk' between Schwannian stroma and neuroblasts promotes neuroblastoma tumor differentiation and inhibits angiogenesis.
Liu S; Tian Y; Chlenski A; Yang Q; Salwen HR; Cohn SL
Cancer Lett; 2005 Oct; 228(1-2):125-31. PubMed ID: 15935552
[TBL] [Abstract][Full Text] [Related]
3. Reconstitution of Schwannian stroma in neuroblastomas using human bone marrow stromal cells.
Du W; Hozumi N; Sakamoto M; Hata J; Yamada T
Am J Pathol; 2008 Oct; 173(4):1153-64. PubMed ID: 18772334
[TBL] [Abstract][Full Text] [Related]
4. Schwann cell-conditioned medium inhibits angiogenesis.
Huang D; Rutkowski JL; Brodeur GM; Chou PM; Kwiatkowski JL; Babbo A; Cohn SL
Cancer Res; 2000 Nov; 60(21):5966-71. PubMed ID: 11085514
[TBL] [Abstract][Full Text] [Related]
5. Cross-talk between Schwann cells and neuroblasts influences the biology of neuroblastoma xenografts.
Liu S; Tian Y; Chlenski A; Yang Q; Zage P; Salwen HR; Crawford SE; Cohn SL
Am J Pathol; 2005 Mar; 166(3):891-900. PubMed ID: 15743800
[TBL] [Abstract][Full Text] [Related]
6. SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis.
Chlenski A; Liu S; Crawford SE; Volpert OV; DeVries GH; Evangelista A; Yang Q; Salwen HR; Farrer R; Bray J; Cohn SL
Cancer Res; 2002 Dec; 62(24):7357-63. PubMed ID: 12499280
[TBL] [Abstract][Full Text] [Related]
7. Prominent microvascular proliferation in clinically aggressive neuroblastoma.
Peddinti R; Zeine R; Luca D; Seshadri R; Chlenski A; Cole K; Pawel B; Salwen HR; Maris JM; Cohn SL
Clin Cancer Res; 2007 Jun; 13(12):3499-506. PubMed ID: 17575212
[TBL] [Abstract][Full Text] [Related]
8. Schwann cell-conditioned medium inhibits angiogenesis in vitro and in vivo.
Huang D; Rutkowski JL; Brodeur GM; Chou PM; Kwiatkowski JL; Babbo A; Cohn SL
Med Pediatr Oncol; 2000 Dec; 35(6):590-2. PubMed ID: 11107124
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological considerations on angiogenic potential in neuroblastoma Schwannian stroma - poor tumours.
Izycka-Swieszewska E; Drozyńska E; Rzepko R; Dembowska B; Grajkowska W; Brozyna A; Perek D; Balcerska A; Jaśkiewicz K
Folia Neuropathol; 2007; 45(1):1-8. PubMed ID: 17357004
[TBL] [Abstract][Full Text] [Related]
10. Selective targeting of interferon γ to stromal fibroblasts and pericytes as a novel therapeutic approach to inhibit angiogenesis and tumor growth.
Bansal R; Tomar T; Ostman A; Poelstra K; Prakash J
Mol Cancer Ther; 2012 Nov; 11(11):2419-28. PubMed ID: 22933708
[TBL] [Abstract][Full Text] [Related]
11. Stromal fibroblasts activated by tumor cells promote angiogenesis in mouse gastric cancer.
Guo X; Oshima H; Kitmura T; Taketo MM; Oshima M
J Biol Chem; 2008 Jul; 283(28):19864-71. PubMed ID: 18495668
[TBL] [Abstract][Full Text] [Related]
12. Role of CXCL13-CXCR5 crosstalk between malignant neuroblastoma cells and Schwannian stromal cells in neuroblastic tumors.
Del Grosso F; Coco S; Scaruffi P; Stigliani S; Valdora F; Benelli R; Salvi S; Boccardo S; Truini M; Croce M; Ferrini S; Longo L; Tonini GP
Mol Cancer Res; 2011 Jul; 9(7):815-23. PubMed ID: 21642390
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples.
Gravina GL; Mancini A; Ranieri G; Di Pasquale B; Marampon F; Di Clemente L; Ricevuto E; Festuccia C
Int J Oncol; 2013 Jun; 42(6):2116-22. PubMed ID: 23589051
[TBL] [Abstract][Full Text] [Related]
14. Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting.
Pietras K; Pahler J; Bergers G; Hanahan D
PLoS Med; 2008 Jan; 5(1):e19. PubMed ID: 18232728
[TBL] [Abstract][Full Text] [Related]
15. Genome analysis and gene expression profiling of neuroblastoma and ganglioneuroblastoma reveal differences between neuroblastic and Schwannian stromal cells.
Coco S; Defferrari R; Scaruffi P; Cavazzana A; Di Cristofano C; Longo L; Mazzocco K; Perri P; Gambini C; Moretti S; Bonassi S; Tonini GP
J Pathol; 2005 Nov; 207(3):346-57. PubMed ID: 16178058
[TBL] [Abstract][Full Text] [Related]
16. Correspondence re: J. Mora et al., Neuroblastic and Schwannian stromal cells of neuroblastoma are derived from a tumoral progenitor cell. Cancer Res., 61: 6892-6898, 2001.
Ambros IM; Amann G; Ambros PF
Cancer Res; 2002 May; 62(10):2986-7; author reply 2988-9. PubMed ID: 12019183
[No Abstract] [Full Text] [Related]
17. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion.
Orimo A; Gupta PB; Sgroi DC; Arenzana-Seisdedos F; Delaunay T; Naeem R; Carey VJ; Richardson AL; Weinberg RA
Cell; 2005 May; 121(3):335-48. PubMed ID: 15882617
[TBL] [Abstract][Full Text] [Related]
18. Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model.
McAlhany SJ; Ressler SJ; Larsen M; Tuxhorn JA; Yang F; Dang TD; Rowley DR
Cancer Res; 2003 Sep; 63(18):5859-65. PubMed ID: 14522910
[TBL] [Abstract][Full Text] [Related]
19. Loss of stromal JUNB does not affect tumor growth and angiogenesis.
Braun J; Strittmatter K; Nübel T; Komljenovic D; Sator-Schmitt M; Bäuerle T; Angel P; Schorpp-Kistner M
Int J Cancer; 2014 Mar; 134(6):1511-6. PubMed ID: 24027048
[TBL] [Abstract][Full Text] [Related]
20. Elevated CXCL1 expression in breast cancer stroma predicts poor prognosis and is inversely associated with expression of TGF-β signaling proteins.
Zou A; Lambert D; Yeh H; Yasukawa K; Behbod F; Fan F; Cheng N
BMC Cancer; 2014 Oct; 14():781. PubMed ID: 25344051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
